The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Valsartan and Hydrochlorothiazide
Valsartan and Hydrochlorothiazide · VALSARTAN 160 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1 · Tablet · Oral · Northwind Health Company, LLC
NDC 82868-0054-30 · 30 TABLET in 1 BOTTLE, PLASTIC · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for valsartan and hydrochlorothiazide (oral solid) in the next 90 days
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- ANDA203145
- TE code
- AB
- Approval date
- Apr 19, 2013
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Valsartan and Hydrochlorothiazide (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| A-S Medication Solutions | VALSARTAN 160 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Macleods Pharmaceuticals Limited | VALSARTAN 160 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Northwind Health Company, LLC | VALSARTAN 160 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| A-S Medication Solutions | VALSARTAN 25 mg/1; HYDROCHLOROTHIAZIDE 160 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Macleods Pharmaceuticals Limited | VALSARTAN 25 mg/1; HYDROCHLOROTHIAZIDE 160 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Northwind Health Company, LLC | VALSARTAN 25 mg/1; HYDROCHLOROTHIAZIDE 160 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| A-S Medication Solutions | HYDROCHLOROTHIAZIDE 25 mg/1; VALSARTAN 160 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Macleods Pharmaceuticals Limited | HYDROCHLOROTHIAZIDE 25 mg/1; VALSARTAN 160 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Northwind Health Company, LLC | HYDROCHLOROTHIAZIDE 25 mg/1; VALSARTAN 160 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Valsartan and Hydrochlorothiazide — NDC 82868-0054-30," retrieved September 3, 2026, https://drugdashboards.com/drug/82868005430.
Free to cite with attribution — see how the data is put together.